Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Monocytosis Prevalence in Polycythemia Vera Evaluated
Am J Hematol; ePub 2017 Mar 28; Barraco, et al
The prevalence of monocytosis in people with polycythemia vera was higher than anticipated in a study involving 267 individuals. Additionally, the mutation profile and age distribution of such patients was found to be similar to that which is seen in those with chronic myelomonocytic leukemia.
Investigators looked at the prevalence, laboratory and molecular correlates, and prognostic significance of monocytosis in participants with PV. Among the results:
- Patients with monocytosis were older and more prone to leukocytosis and TET2/SRSF2 mutations.
- After adjusting for certain variables, patients with a higher absolute monocyte count had poorer overall survival.
- Unfavorable karyotype, older age, and higher white blood cell count also played a role in overall survival.
Barraco D, Cerquozzi S, Gangat N, et al. Monocytosis in polycythemia vera: Clinical and molecular correlates. [Published online ahead of print March 28, 2017]. Am J Hematol. doi:10.1002/ajh.24740.
This Week's Must Reads
Must Reads in Hematologic Malignancies
Long-term ibrutinib data in older patients, Barr PM et al. Haematologica. 2018;103(9):1502-10
Prognostic Score System for Patients with PMF, J Clin Oncol; ePub 2017 Dec 9; Gugliemelli, et al
These Patients Are More Apt to Be Depressed, Ann Hematol; ePub 2017 Dec 7; Shreders, et al
Survival Length Shortest in These Patients with MF, Eur J Haematol; ePub 2017 Dec 11; Masarova, et al
The Value of Ruxolitinib Before and After AlloSCT, Blood; ePub 2017 Dec 7; Poulose, Malysz, et al